Home Search
infectious diseases - search results
If you're not happy with the results, please do another search
Contemporary immunology and its relationship to medicine
Peter Bretscher, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, explores important immunological questions
Autopsies: The dead serving the living
How forensic autopsies are not only used to determine a cause of death, but also to support medical research and development
Foundations of Immunology and their Pertinence to Medicine
Peter Bretscher at the University of Saskatchewan discusses his research in Immunology.
Inequalities in healthcare caused by bias in medical devices
An independent review is being launched to analyse the potential bias in medical devices affecting ethnic groups and gender disparities in healthcare.
Emphasising vaccines and immunotherapeutics research worldwide
Here, Open Access Government interview Dr Babita Agrawal, Professor in the Department of Surgery, University of Alberta to discuss the continued need for research into vaccines and immunotherapeutics.
Scientists find link between health policies and political favouritism
A new study reveals that WHO public health policies are poorly implemented in countries where corporations have influence via corruption and political favouritism.
Mature students must retrain to future proof their career chances
Professor Martin Jones, Vice-Chancellor and Chief Executive Designate at Staffordshire University, discusses why it is important for mature students to retrain to future proof their career chances.
Filling in the gaps of brain immune response
Open Access Government spoke to Dr Robyn S. Klein, MD, PhD, about her ground-breaking work in neuroimmunology and the path to understanding the links between viral encephalitis and memory disorders.
Impact of COVID-19 in African countries
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, offers preliminary context about the impact of the COVID-19 pandemic in most African countries, starting with lessons to be learned from previous outbreaks.
Double vaccination reduces risk of Long COVID by 49%
Double vaccinated adults are 49% less likely to have Long COVID if they were to contract COVID-19, according to a new study.
More must be done to tackle diabetes
Professor Andrew Boulton, President & Professor Akhtar Hussain, President-Elect of the International Diabetes Federation, argue that while there has been a century of saving lives, more must be done to tackle diabetes.
COVID-19: Challenges of vaccination logistics
The challenges of vaccination logistics during the COVID-19 pandemic are charted in this updated view, written by Zisis Kozlakidis and John Litaker.
European commission approves contract for Novavax vaccine
The European Commission has approved a new contract that will allow Member States to purchase up to 100 million doses of the Novavax vaccine.
Clinical trial to investigate vaccine dose interval for pregnant women
A new clinical trial, funded by the UK government, will investigate the best gap between the first and second COVID-19 vaccine dose for pregnant women.
Pfizer to create COVID vaccine against Delta variant
Pfizer say they will develop a new COVID vaccine to function as a booster against the Delta variant.
UK study says saRNA COVID vaccines work in 87% of people
While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.
Learning from COVID-19 and the continuing malaria fight
Michelle Davis, Head of External Relations at Malaria Consortium, shares with us what we need to know about learning from COVID-19 and the continuing fight against malaria.
Canada: Infection & immunity focus
The Canadian Institutes of Health Research, part of the Government of Canada, has an Institute of Infection and Immunity. Here, we gain a flavour of what they do.
Study says international travel increases antimicrobial resistance
A new study confirms that antimicrobial resistance increases as people travel internationally, with one scientist commenting that the world faces "a worrisome problem on the horizon".
Scientists say vaccines less effective against Delta variant
According to a new study, the antibodies created by the Pfizer vaccine are on average less effective against the Delta variant.
